NEW YORK (AP) — Stocks that moved heavily or traded substantially Wednesday:

Momenta Pharmaceuticals Inc., up $21.31 to $52.12.

Johnson & Johnson is buying the biotechnology company for $6.5 billion.

Hudson Ltd., up $2.33 to $7.46.

Dufry Group AG, the travel retailer's majority owner, is buying the remaining shares of the company.

BioMarin Pharmaceutical Inc., down $41.82 to $76.72.

The Food and Drug Administration wants more information on the drug developer's potential hemophilia treatment before considering its approval.

TJX Companies Inc., down $3.09 to $54.36.

The owner of T.J. Maxx, Marshalls and other retail chains reported disappointing second-quarter earnings.

Cree Inc., down $5.13 to $63.31.

The maker of lighting products gave investors a weak fiscal first-quarter profit forecast.

Sorrento Therapeutics Inc., down $1.22 to $11.06.

The company fired chief financial officer Jiong Shao a week after saying it had uncovered a fraudulent attempt to manipulate its stock.

Gilead Sciences Inc., down $3.36 to $65.70.

The Food and Drug Administration rejected the biotechnology company's rheumatoid arthritis drug.

Target Corp., up $17.32 to $154.22.

The retailer blew away Wall Street’s second-quarter profit forecasts thanks to surging sales.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News